David Scott Fisher - 02 Jun 2026 Form 4 Insider Report for HARTE HANKS INC (HHS)

Reporting relationship: President
Issuer ticker: HHS
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jun 2026, 10:54:03 UTC
Prior SEC filing: 16 Jul 2025
Source filing: View source filing
Reporting owner signature: David A Garrison for David Scott Fisher

Key filing fact

David Scott Fisher filed Form 4 for HARTE HANKS INC (HHS) on 05 Jun 2026.

Key facts

This page summarizes David Scott Fisher's Form 4 filing for HARTE HANKS INC (HHS).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 10:54.

Change

Previous filing in this sequence was filed on 16 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002076964 Primary reporting owner

Fisher David Scott

Relationship: President
Address: 1 EXECUTIVE DR, CHELMSFORD
Signature: David A Garrison for David Scott Fisher
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HHS transaction

Common Stock - Restricted Stock Units

Other

Transaction value
Shares: -18,790
Change %: -23%
Price: $2.62^*
Shares after: 61,210
Date: 02 Jun 2026
Ownership: Shares held by Harte Hanks until vested
Footnotes: F1

HHS transaction

Common Stock - Restricted Stock Units

Tax liability

Transaction value
Shares: -7,876
Change %: -13%
Price: $2.62^*
Shares after: 53,334
Date: 02 Jun 2026
Ownership: Shares held by Harte Hanks until vested
Footnotes: F2

HHS transaction

Common Stock

Other

Transaction value
Shares: +18,790
Change %
Price: $2.62^*
Shares after: 18,790
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HHS holding Derivative

Option to buy Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,400
Date: 02 Jun 2026
Ownership: Shares held by Harte Hanks
Underlying class: Common Stock
Underlying amount: 32,400
Exercise price: $5.34
Footnotes: F3, F4

HHS holding Derivative

Option to buy Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,400
Date: 02 Jun 2026
Ownership: Shares held by Harte Hanks
Underlying class: Common Stock
Underlying amount: 32,400
Exercise price: $4.55
Footnotes: F5, F6

HHS holding Derivative

Option to buy Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,300
Date: 02 Jun 2026
Ownership: Shares held by Harte Hanks
Underlying class: Common Stock
Underlying amount: 32,300
Exercise price: $7.74
Footnotes: F7, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

RSU shares vested and converted from indirect owned non-derivatives to direct owned non-derivative shares.

Footnote F2

Represents shares withheld to offset the reporting person's tax obligations upon vesting of RSU's.

Footnote F3

The first of three tranches, 10,800 shares, vested on January 27, 2026.

Footnote F4

Award No 50105. The participant was granted 32,400 NQ stock options on January 27, 2025 under the Harte Hanks, Inc. 2023 Inducement Equity Incentive Plan. The options vest and become exercisable as to 1/3rd of the underlying shares on each of the first three anniversaries of January 27, 2025.

Footnote F5

The first of three tranches, 10,800 shares, vested on June 2, 2026.

Footnote F6

Award No 50106. The participant was granted 32,400 NQ stock options on June 2, 2025 under the Harte Hanks, Inc. 2023 Inducement Equity Incentive Plan. The options vest and become exercisable as to 1/3rd of the underlying shares on each of the first three anniversaries of June 2, 2025.

Footnote F7

The first two of three tranches, totaling 21,533 shares, vested on January 29, 2025 and 2026.

Footnote F8

Award No 50102. The participant was granted 32,300 NQ stock options on January 29, 2024 under the Harte Hanks, Inc. 2023 Inducement Equity Incentive Plan. The options vest and become exercisable as to 1/3rd of the underlying shares on each of the first three anniversaries of January 29, 2024.